SPIOLTO RESPIMAT is indicated for the long term, once-daily maintenance treatment in patients with COPD (including chronic bronchitis and emphysema), to reduce airflow obstruction, to improve quality of life, to reduce associated dyspnoea, to improve exercise tolerance and to reduce exacerbations.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
